[BRNS] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
20-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -23.96%
YoY- 17.68%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 14,969 0 0 5,369 0 334 468 901.28%
PBT -8,132 -17,663 -16,142 -18,268 -14,713 -24,960 -18,739 -42.59%
Tax -18 -701 -631 -827 -603 -1,136 -516 -89.25%
NP -8,114 -16,950 -15,480 -17,443 -14,072 -23,802 -18,180 -41.51%
Tax Rate - - - - - - - -
Total Cost 23,083 16,950 15,480 22,813 14,072 24,136 18,648 15.24%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -54.21 0.00 0.00 -324.88 0.00 -7,126.35 -3,884.62 -94.15%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.21 -0.43 -0.40 -0.45 -0.37 -0.62 -0.48 -42.28%
EPS Diluted -0.21 -0.43 -0.40 -0.45 -0.37 -0.62 -0.48 -42.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.